Many thanks to Health Economist and Influencer Jane Sarasohn-Kahn for her profile of NephCure Kidney International on her wildly popular blog, Health Populi. We had a great time discussing the NKI mission, Patient Powered Research Networks, ringing the opening bell of the NYSE, and the online future of NephCure. An excerpt from the opening paragraph appears below. We encourage you to read, comment, and share the entire article here. Thanks to everyone for your support!
The burden of chronic kidney disease (CKD) is growing, with one in 10 U.S. adults having some level of CKD. End-stage renal disease (ESRD) is the last phase of CKD, when dialysis or an organ transplant are required. Nephrotic syndrome is one of the most common forms of CKD, and focal segmental glomerulosclerosis — FSGS — is the fastest-growing cause of nephrotic syndrome in children, and the second-leading cause of kidney failure in children.